文献速递肾移植遗传性与小管间质肾病血液净化与透析

RNA干扰药物与1型原发性高草酸尿症患者的移植策略

RNA interference medication and transplantation procedures in patients with primary hyperoxaluria type 1.
PubMed 文献 · Nephrol Dial Transplant · 2026-01-01

该研究报道17例接受血液透析的1型原发性高草酸尿症(PH1)患者使用RNA干扰(RNAi)药物(lumasiran、nedosiran等)的经验,通过监测透析前血浆草酸盐(Pox)和全身草酸盐沉积分级(SOG)来指导移植决策。结论提示Pox不应作为决定移植术式的唯一参数,SOG无恶化且对维生素B6敏感或RNAi治疗有效的患者可考虑孤立肾移植,而严重或进展性全身草酸盐沉积、RNAi治疗期间Pox高及最大程度透析应重新考虑联合或序贯肝肾移植。

要点

  • Pox不应作为决定移植术式的唯一参数,需结合SOG动态评估。
  • SOG无恶化且对维生素B6敏感或RNAi有效的患者可考虑孤立肾移植。
  • 严重或进展性全身草酸盐沉积、RNAi期间Pox高及最大透析应倾向联合或序贯肝肾移植。

核心结论

  • Pox不应是决定移植术式的唯一参数。
  • SOG无恶化、对维生素B6敏感或RNAi治疗有效的患者可考虑孤立肾移植。
  • 严重或进展性全身草酸盐沉积、RNAi治疗期间Pox高及最大程度透析应重新考虑联合或序贯肝肾移植而非孤立肾移植。
  • 诊断时即有严重全身草酸盐沉积的患者死亡率仍高。

研究设计与样本

  • 报告17例接受血液透析的PH1患者,使用lumasiran(7例,1-68岁,6例女性)、lumasiran后换用nedosiran(2例,均为6.5岁男性)、双RNAi(4例,37岁,3例婴儿,均为男性)和nedosiran(4例,11-58岁,2例女性)。
  • 监测透析前血浆草酸盐(Pox),并通过骨磁共振成像和斑点超声心动图主要评估全身草酸盐沉积分级(SOG),在治疗开始前及治疗期间反复评估。

主要发现

  • 4例患者接受了孤立肾移植,其中2例成功、2例复发。
  • 其他患者中,RNAi治疗下Pox值的变化以及由此反映的SOG进展和临床恶化是移植决策的重要依据。
  • 基于上述评估,目前5例计划行孤立肾移植,4例计划行肝肾移植(其中1例已行肝移植)。
  • 3例患者死亡。

临床怎么用

  • 对于PH1合并肾衰竭患者,在RNAi治疗下应动态监测Pox和SOG以指导移植决策。
  • SOG无恶化且对维生素B6敏感或RNAi治疗有效的患者可考虑孤立肾移植。
  • 严重或进展性全身草酸盐沉积、RNAi治疗期间Pox高及最大程度透析的患者应优先考虑联合或序贯肝肾移植。
  • 诊断时即有严重全身草酸盐沉积的患者需警惕高死亡率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND HYPOTHESIS: Defective hepatic alanine-glyoxylate aminotransferase (AGT) leads to oxalate overproduction in primary hyperoxaluria type 1 (PH1). Nedosiran and lumasiran are RNA interference (RNAi) agents inhibiting oxalate production. In PH1 patients with kidney failure, isolated kidney transplantation (iKTx) might be possible with RNAi medication. METHODS: We report on 17 PH1 patients on hemodialysis, who received lumasiran (7 patients, 1-68 years, 6 females), lumasiran post-nedosiran (2 patients, both 6.5 years, male), double RNAi (dRNAi) (4 patients, 37 years, 3 infants, all male) and nedosiran (4 patients, 11-58 years, 2 female). Plasma oxalate (Pox) pre-HD was measured and systemic oxalate grading (SOG) was evaluated mainly by bone magnetic resonance imaging and speckle echocardiography, before the start of and repeatedly during treatment. RESULTS: In four patients iKTx was performed, being successful or with recurrence in two patients each. In others, development of Pox values under RNAi treatment and thus SOG increment and clinical deterioration were profound arguments for transplant decisions. Based on that, iKTx is now planned in five and liver/kidney Tx in four patients (one liver already transplanted). Three patients have died. CONCLUSION: Pox should not be the sole parameter by which to decide on Tx procedure. In patients with minor oxalate deposition, no SOG deterioration and sensitivity to vitamin B6 or under efficacious RNAi treatment, iKTx can be considered. Severe (and deteriorating) systemic oxalosis, high Pox during RNAi treatment and maximum dialysis should lead to reconsidering combined or sequential LKTx rather than iKTx. Patients with severe systemic oxalosis at time of diagnosis still have a high mortality rate.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Martin-Higueras C, Borghese L, König J, et al. RNA interference medication and transplantation procedures in patients with primary hyperoxaluria type 1. Nephrol Dial Transplant. 2026. PMID: 41042231. doi:10.1093/ndt/gfaf202

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。